<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32819425</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Defining novel functions for cerebrospinal fluid in ALS pathophysiology.</ArticleTitle><Pagination><StartPage>140</StartPage><MedlinePgn>140</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">140</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-020-01018-0</ELocationID><Abstract><AbstractText>Despite the considerable progress made towards understanding ALS pathophysiology, several key features of ALS remain unexplained, from its aetiology to its epidemiological aspects. The glymphatic system, which has recently been recognised as a major clearance pathway for the brain, has received considerable attention in several neurological conditions, particularly Alzheimer's disease. Its significance in ALS has, however, been little addressed. This perspective article therefore aims to assess the possibility of CSF contribution in ALS by considering various lines of evidence, including the abnormal composition of ALS-CSF, its toxicity and the evidence for impaired CSF dynamics in ALS patients. We also describe a potential role for CSF circulation in determining disease spread as well as the importance of CSF dynamics in ALS neurotherapeutics. We propose that a CSF model could potentially offer additional avenues to explore currently unexplained features of ALS, ultimately leading to new treatment options for&#xa0;people with ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ng Kee Kwong</LastName><ForeName>Koy Chong</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh bioQuarter, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Arpan R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0002-5715-5025</Identifier><AffiliationInfo><Affiliation>UK Dementia Research Institute at University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh bioQuarter, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nedergaard</LastName><ForeName>Maiken</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Translational Neuromedicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandran</LastName><ForeName>Siddharthan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at University of Edinburgh, Edinburgh, UK. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh bioQuarter, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, UK. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Development and Repair, inStem, Bangalore, India. siddharthan.chandran@ed.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/R001162/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RF1 NS110049</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MEHTA/JUL17/948-795</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS100366</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG057575</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ageing</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Glymphatic system</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32819425</ArticleId><ArticleId IdType="pmc">PMC7439665</ArticleId><ArticleId IdType="doi">10.1186/s40478-020-01018-0</ArticleId><ArticleId IdType="pii">10.1186/s40478-020-01018-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abe K, Fujimura H, Toyooka K, Hazama T, Hirono N, Yorifuji S, Yanagihara T. Single-photon emission computed tomographic investigation of patients with motor-neuron disease. Neurology. 1993;43:1569&#x2013;1573. doi: 10.1212/Wnl.43.8.1569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/Wnl.43.8.1569</ArticleId><ArticleId IdType="pubmed">8351013</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, Fujimura H, Toyooka K, Sakoda S, Yorifuji S, Yanagihara T. Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci. 1997;148:95&#x2013;100. doi: 10.1016/s0022-510x(96)05338-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(96)05338-5</ArticleId><ArticleId IdType="pubmed">9125395</ArticleId></ArticleIdList></Reference><Reference><Citation>Achariyar TM, Li BM, Peng WG, Verghese PB, Shi Y, McConnell E, Benraiss A, Kasper T, Song W, Takano T, et al. Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation. Mol Neurodegener. 2016;11:74. doi: 10.1186/s13024-016-0138-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0138-8</ArticleId><ArticleId IdType="pmc">PMC5146863</ArticleId><ArticleId IdType="pubmed">27931262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Newcombe RE, Piper AJ, Lewis SJ, Yee BJ, Kiernan MC, Grunstein RR. Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev. 2016;26:33&#x2013;42. doi: 10.1016/j.smrv.2015.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2015.05.007</ArticleId><ArticleId IdType="pubmed">26166297</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn JH, Cho H, Kim JH, Kim SH, Ham JS, Park I, Suh SH, Hong SP, Song JH, Hong YK, et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature. 2019;572:62&#x2013;66. doi: 10.1038/s41586-019-1419-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1419-5</ArticleId><ArticleId IdType="pubmed">31341278</ArticleId></ArticleIdList></Reference><Reference><Citation>Akanuma S, Sakurai T, Tachikawa M, Kubo Y, Hosoya K. Transporter-mediated L-glutamate elimination from cerebrospinal fluid: possible involvement of excitatory amino acid transporters expressed in ependymal cells and choroid plexus epithelial cells. Fluids Barriers CNS. 2015;12:11. doi: 10.1186/s12987-015-0006-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-015-0006-x</ArticleId><ArticleId IdType="pmc">PMC4425921</ArticleId><ArticleId IdType="pubmed">25925580</ArticleId></ArticleIdList></Reference><Reference><Citation>Albeck MJ, Skak C, Nielsen PR, Olsen KS, Borgesen SE, Gjerris F. Age dependency of resistance to cerebrospinal fluid outflow. J Neurosurg. 1998;89:275&#x2013;278. doi: 10.3171/jns.1998.89.2.0275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/jns.1998.89.2.0275</ArticleId><ArticleId IdType="pubmed">9688123</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16:745&#x2013;751. doi: 10.1111/j.1468-1331.2009.02586.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02586.x</ArticleId><ArticleId IdType="pmc">PMC3093130</ArticleId><ArticleId IdType="pubmed">19475756</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrafiah AR. From mouse models to human disease: an approach for amyotrophic lateral sclerosis. In Vivo. 2018;32:983&#x2013;998. doi: 10.21873/invivo.11339.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.11339</ArticleId><ArticleId IdType="pmc">PMC6199613</ArticleId><ArticleId IdType="pubmed">30150420</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziata P, Volpi N. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients. Acta Neurol Scand. 1985;72:61&#x2013;64. doi: 10.1111/j.1600-0404.1985.tb01548.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1985.tb01548.x</ArticleId><ArticleId IdType="pubmed">4050318</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolski S, Nikolic J, Bugarski-Prokopljevic C, Miletic V, Pavlovic S, Filipovic S. Serum and CSF immunological findings in ALS. Acta Neurol Scand. 1991;83:96&#x2013;98. doi: 10.1111/j.1600-0404.1991.tb04656.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1991.tb04656.x</ArticleId><ArticleId IdType="pubmed">2017904</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, Wiig H, Alitalo K. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212:991&#x2013;999. doi: 10.1084/jem.20142290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20142290</ArticleId><ArticleId IdType="pmc">PMC4493418</ArticleId><ArticleId IdType="pubmed">26077718</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Cashman NR. Prion-like mechanisms in amyotrophic lateral sclerosis. Handb Clin Neurol. 2018;153:337&#x2013;354. doi: 10.1016/B978-0-444-63945-5.00018-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63945-5.00018-0</ArticleId><ArticleId IdType="pubmed">29887144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt S, Sinyavskaya O, Siemienski Z, Rosario AM, Li A, Crosby KW, Cruz PE, DiNunno NM, Janus C, et al. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice. Mol Therapy. 2015;23:53&#x2013;62. doi: 10.1038/mt.2014.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2014.180</ArticleId><ArticleId IdType="pmc">PMC4426802</ArticleId><ArticleId IdType="pubmed">25228069</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, Carmeliet P, Mazarakis ND. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004;429:413&#x2013;417. doi: 10.1038/nature02544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02544</ArticleId><ArticleId IdType="pubmed">15164063</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Wood-Allum CA, Sargsyan SA, Walsh T, Cox LE, Monk PN, Shaw PJ. Contrasting effects of cerebrospinal fluid from motor neuron disease patients on the survival of primary motor neurons cultured with or without glia. Amyotroph Lateral Scler. 2011;12:257&#x2013;263. doi: 10.3109/17482968.2011.560672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.560672</ArticleId><ArticleId IdType="pubmed">21366496</ArticleId></ArticleIdList></Reference><Reference><Citation>Barschke P, Oeckl P, Steinacker P, Ludolph A, Otto M. Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis. Exp Rev Proteom. 2017;14:769&#x2013;777. doi: 10.1080/14789450.2017.1365602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14789450.2017.1365602</ArticleId><ArticleId IdType="pubmed">28799854</ArticleId></ArticleIdList></Reference><Reference><Citation>Bataveljic D, Nikolic L, Milosevic M, Todorovic N, Andjus PR. Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1G93A rat model. Glia. 2012;60:1991&#x2013;2003. doi: 10.1002/glia.22414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22414</ArticleId><ArticleId IdType="pubmed">22987392</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra R, Lee CW. Mouse models of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis/frontotemporal dementia. Front Cell Neurosci. 2017;11:196. doi: 10.3389/fncel.2017.00196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00196</ArticleId><ArticleId IdType="pmc">PMC5498553</ArticleId><ArticleId IdType="pubmed">28729824</ArticleId></ArticleIdList></Reference><Reference><Citation>Benveniste H, Liu X, Koundal S, Sanggaard S, Lee H, Wardlaw J. The glymphatic system and waste clearance with brain aging: a review. Gerontology. 2019;65:106&#x2013;119. doi: 10.1159/000490349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000490349</ArticleId><ArticleId IdType="pmc">PMC6329683</ArticleId><ArticleId IdType="pubmed">29996134</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertel O, Malessa S, Sluga E, Hornykiewicz O. Amyotrophic-lateral-sclerosis - changes of noradrenergic and serotonergic transmitter systems in the spinal-cord. Brain Res. 1991;566:54&#x2013;60. doi: 10.1016/0006-8993(91)91680-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(91)91680-Y</ArticleId><ArticleId IdType="pubmed">1726065</ArticleId></ArticleIdList></Reference><Reference><Citation>Biceroglu H, Albayram S, Ogullar S, Hasiloglu ZI, Selcuk H, Yuksel O, Karaaslan B, Yildiz C, Kiris A. Direct venous spinal reabsorption of cerebrospinal fluid: a new concept with serial magnetic resonance cisternography in rabbits. J Neurosurg Spine. 2012;16:394&#x2013;401. doi: 10.3171/2011.12.SPINE11108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2011.12.SPINE11108</ArticleId><ArticleId IdType="pubmed">22243405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998;39:1594&#x2013;1600.</Citation><ArticleIdList><ArticleId IdType="pubmed">9717719</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Corcia P, Moreau C, Veau S, Fournier C, Vourc&#x2019;h P, Emond P, Gordon P, Pradat PF, Praline J, et al. H-1-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS ONE. 2010;5:e13223. doi: 10.1371/journal.pone.0013223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013223</ArticleId><ArticleId IdType="pmc">PMC2951909</ArticleId><ArticleId IdType="pubmed">20949041</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Corcia P, Pradat PF, Bocca C, Gordon PH, Veyat-Durebex C, Mavel S, Nadal-Desbarats L, Moreau C, Devos D, et al. Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. J Proteome Res. 2013;12:3746&#x2013;3754. doi: 10.1021/pr400376e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr400376e</ArticleId><ArticleId IdType="pubmed">23859630</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Veyrat-Durebex C, Bocca C, Patin F, Vourc&#x2019;h P, Kouassi Nzoughet J, Lenaers G, Andres CR, Simard G, Corcia P, et al. Lipidomics reveals cerebrospinal-fluid signatures of ALS. Sci Rep. 2017;7:17652. doi: 10.1038/s41598-017-17389-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17389-9</ArticleId><ArticleId IdType="pmc">PMC5732162</ArticleId><ArticleId IdType="pubmed">29247199</ArticleId></ArticleIdList></Reference><Reference><Citation>Boentert M. Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives. Nat Sci Sleep. 2019;11:97&#x2013;111. doi: 10.2147/Nss.S183504.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/Nss.S183504</ArticleId><ArticleId IdType="pmc">PMC6701267</ArticleId><ArticleId IdType="pubmed">31496852</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonini D, Filippini A, La Via L, Fiorentini C, Fumagalli F, Colombi M, Barbon A. Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons. RNA Biol. 2015;12:43&#x2013;53. doi: 10.1080/15476286.2015.1008365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2015.1008365</ArticleId><ArticleId IdType="pmc">PMC4615659</ArticleId><ArticleId IdType="pubmed">25625181</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen S, Ateh DD, Deinhardt K, Bird MM, Price KM, Baker CS, Robson JC, Swash M, Shamsuddin W, Kawar S, et al. The phagocytic capacity of neurones. Eur J Neurosci. 2007;25:2947&#x2013;2955. doi: 10.1111/j.1460-9568.2007.05554.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2007.05554.x</ArticleId><ArticleId IdType="pubmed">17561810</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985;76:1501&#x2013;1513. doi: 10.1172/JCI112130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI112130</ArticleId><ArticleId IdType="pmc">PMC424114</ArticleId><ArticleId IdType="pubmed">3932467</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K. Amyotrophic lateral sclerosis&#x2013;a model of corticofugal axonal spread. Nat Rev Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer S, Gunther R, Sterneckert J, Glass H, Hermann A. Human spinal motor neurons are particularly vulnerable to cerebrospinal fluid of amyotrophic lateral sclerosis patients. Int J Mol Sci. 2020;21(10):3564. doi: 10.3390/ijms21103564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103564</ArticleId><ArticleId IdType="pmc">PMC7278966</ArticleId><ArticleId IdType="pubmed">32443559</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer S, Zimyanin V, Hermann A. Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis. J Neural Transm (Vienna) 2018;125:591&#x2013;613. doi: 10.1007/s00702-018-1851-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-018-1851-y</ArticleId><ArticleId IdType="pubmed">29417336</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Zielger MG, Lake CR, Wood JH, Enna SJ, Engel WK. Cerebrospinal-fluid norepinephrine and free gamma-aminobutyric acid in amyotrophic lateral sclerosis. Brain Res Bull. 1980;5:765&#x2013;768. doi: 10.1016/0361-9230(80)90126-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0361-9230(80)90126-4</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012;11:232&#x2013;240. doi: 10.1016/S1474-4422(12)70014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70014-5</ArticleId><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Chancellor AM, Hendry A, Caird FI, Warlow CP, Weir AI. Motor neuron disease: a disease of old age. Scott Med J. 1993;38:178&#x2013;182. doi: 10.1177/003693309303800606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/003693309303800606</ArticleId><ArticleId IdType="pubmed">8146636</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Durazo A, Sohn SH, Strong CD, Gralla EB, Whitelegge JP, Valentine JS. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci USA. 2008;105:18663&#x2013;18668. doi: 10.1073/pnas.0807058105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807058105</ArticleId><ArticleId IdType="pmc">PMC2585484</ArticleId><ArticleId IdType="pubmed">19022905</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13:1228&#x2013;1240. doi: 10.1016/S1474-4422(14)70167-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70167-X</ArticleId><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SM, Norris FH. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve. 1993;16:864&#x2013;869. doi: 10.1002/mus.880160810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880160810</ArticleId><ArticleId IdType="pubmed">8332139</ArticleId></ArticleIdList></Reference><Reference><Citation>Cid C, Alvarez-Cermeno JC, Regidor I, Salinas M, Alcazar A. Low concentrations of glutamate induce apoptosis in cultured neurons: implications for amyotrophic lateral sclerosis. J Neurol Sci. 2003;206:91&#x2013;95. doi: 10.1016/s0022-510x(02)00339-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(02)00339-8</ArticleId><ArticleId IdType="pubmed">12480091</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark IA, Vissel B. Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents. J Neuroinflammation. 2016;13:236. doi: 10.1186/s12974-016-0708-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0708-2</ArticleId><ArticleId IdType="pmc">PMC5011997</ArticleId><ArticleId IdType="pubmed">27596607</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, de Carvalho M. Exploring cerebrospinal fluid IgG N-glycosylation as potential biomarker for amyotrophic lateral sclerosis. Mol Neurobiol. 2019;56:5729&#x2013;5739. doi: 10.1007/s12035-019-1482-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1482-9</ArticleId><ArticleId IdType="pubmed">30674035</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P, Hugon J, Sindou P, Vallat JM, Dumas M. Cell-culture evidence for neuronal degeneration in amyotrophic-lateral-sclerosis being linked to glutamate ampa kainate receptors. Lancet. 1993;341:265&#x2013;268. doi: 10.1016/0140-6736(93)92615-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)92615-Z</ArticleId><ArticleId IdType="pubmed">8093916</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Mesquita S, Fu Z, Kipnis J. The meningeal lymphatic system: a new player in neurophysiology. Neuron. 2018;100:375&#x2013;388. doi: 10.1016/j.neuron.2018.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.022</ArticleId><ArticleId IdType="pmc">PMC6268162</ArticleId><ArticleId IdType="pubmed">30359603</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Mesquita S, Louveau A, Vaccari A, Smirnov I, Cornelison RC, Kingsmore KM, Contarino C, Onengut-Gumuscu S, Farber E, Raper D, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer&#x2019;s disease. Nature. 2018;560:185&#x2013;191. doi: 10.1038/s41586-018-0368-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0368-8</ArticleId><ArticleId IdType="pmc">PMC6085146</ArticleId><ArticleId IdType="pubmed">30046111</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J, Lin W, Zheng M, Liu Q, He B, Luo C, Lu X, Pei Z, Su H, Yao X. Alterations in AQP4 expression and polarization in the course of motor neuron degeneration in SOD1G93A mice. Mol Med Rep. 2017;16:1739&#x2013;1746. doi: 10.3892/mmr.2017.6786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6786</ArticleId><ArticleId IdType="pmc">PMC5562093</ArticleId><ArticleId IdType="pubmed">28627708</ArticleId></ArticleIdList></Reference><Reference><Citation>Demestre M, Pullen A, Orrell RW, Orth M. ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures. J Neurochem. 2005;94:268&#x2013;275. doi: 10.1111/j.1471-4159.2005.03184.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03184.x</ArticleId><ArticleId IdType="pubmed">15953369</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis. 2005;2:202&#x2013;207. doi: 10.1159/000089626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089626</ArticleId><ArticleId IdType="pubmed">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011;258:613&#x2013;617. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreha-Kulaczewski S, Joseph AA, Merboldt KD, Ludwig HC, Gartner J, Frahm J. Inspiration is the major regulator of human CSF flow. J Neurosci. 2015;35:2485&#x2013;2491. doi: 10.1523/jneurosci.3246-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.3246-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605608</ArticleId><ArticleId IdType="pubmed">25673843</ArticleId></ArticleIdList></Reference><Reference><Citation>Du AT, Jahng GH, Hayasaka S, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin KP, Miller BL, Weiner MW, Schuff N. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology. 2006;67:1215&#x2013;1220. doi: 10.1212/01.wnl.0000238163.71349.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000238163.71349.78</ArticleId><ArticleId IdType="pmc">PMC1779761</ArticleId><ArticleId IdType="pubmed">17030755</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A, De Aguilar JLG, Bonnefont-Rousselot D, Bittar R, Seilhean D, Hauw JJ, Lacomblez L, Loeffler JP, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Eide PK, Ringstad G. Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: a glymphatic magnetic resonance imaging study. J Cerebr Blood F Met. 2019;39:1355&#x2013;1368. doi: 10.1177/0271678x18760974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678x18760974</ArticleId><ArticleId IdType="pmc">PMC6668515</ArticleId><ArticleId IdType="pubmed">29485341</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kim S, Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve. 1992;15:219&#x2013;224. doi: 10.1002/mus.880150215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880150215</ArticleId><ArticleId IdType="pubmed">1549143</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelborghs S, Vloeberghs E, Le Bastard N, Van Buggenhout M, Marien P, Somers N, Nagels G, Pickut BA, De Deyn PP. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochem Int. 2008;52:1052&#x2013;1060. doi: 10.1016/j.neuint.2007.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2007.10.018</ArticleId><ArticleId IdType="pubmed">18093695</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan AM, Holtzman DM, Munson G, Mathur T, Schneider D, Chang LK, Getz GS, Reardon CA, Lukens J, Shah JA, et al. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J Biol Chem. 1999;274:30001&#x2013;30007. doi: 10.1074/jbc.274.42.30001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.42.30001</ArticleId><ArticleId IdType="pubmed">10514484</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, Li D, Thal DR, Walther P, Ludolph AC, et al. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol. 2015;211:897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Santiago R, Hoenig S, Lichtner P, Sperfeld AD, Sharma M, Berg D, Weichenrieder O, Illig T, Eger K, Meyer T, et al. Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis. J Neurol. 2009;256:1337&#x2013;1342. doi: 10.1007/s00415-009-5124-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5124-4</ArticleId><ArticleId IdType="pmc">PMC2921066</ArticleId><ArticleId IdType="pubmed">19363631</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiszman ML, Ricart KC, Latini A, Rodriguez G, Sica RE. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses. Acta Neurol Scand. 2010;121:120&#x2013;126. doi: 10.1111/j.1600-0404.2009.01200.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2009.01200.x</ArticleId><ArticleId IdType="pubmed">19804473</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchi C, Bianchi E, Pupillo E, Poloni M, Nobili A, Fortino I, Bortolotti A, Merlino L, Beghi E. Angiotensin-converting enzyme inhibitors and motor neuron disease: an unconfirmed association. Amyotroph Lat Scl Fr. 2016;17:385&#x2013;388. doi: 10.3109/21678421.2016.1143515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1143515</ArticleId><ArticleId IdType="pubmed">26913547</ArticleId></ArticleIdList></Reference><Reference><Citation>Fray AE, Ince PG, Banner SJ, Milton ID, Usher PA, Cookson MR, Shaw PJ. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study. Eur J Neurosci. 1998;10:2481&#x2013;2489. doi: 10.1046/j.1460-9568.1998.00273.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9568.1998.00273.x</ArticleId><ArticleId IdType="pubmed">9767379</ArticleId></ArticleIdList></Reference><Reference><Citation>Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:113&#x2013;117. doi: 10.1080/17482960802295192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802295192</ArticleId><ArticleId IdType="pubmed">18792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellera C, Colombrita C, Ticozzi N, Castellotti B, Bragato C, Ratti A, Taroni F, Silani V. Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics. 2008;9:33&#x2013;40. doi: 10.1007/s10048-007-0111-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-007-0111-3</ArticleId><ArticleId IdType="pubmed">18087731</ArticleId></ArticleIdList></Reference><Reference><Citation>Gille B, De Schaepdryver M, Dedeene L, Goossens J, Claeys KG, Van Den Bosch L, Tournoy J, Van Damme P, Poesen K. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry. 2019 doi: 10.1136/jnnp-2018-319586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319586</ArticleId><ArticleId IdType="pubmed">31175169</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Pinedo U, Galan L, Yanez M, Matias-Guiu J, Valencia C, Guerrero-Sola A, Lopez-Sosa F, Brin JR, Benito-Martin MS, Leon-Espinosa G, et al. Histological changes in the rat brain and spinal cord following prolonged intracerebroventricular infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients are similar to those caused by the disease. Neurologia. 2018;33:211&#x2013;223. doi: 10.1016/j.nrl.2016.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2016.07.002</ArticleId><ArticleId IdType="pubmed">27570180</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray E, Larkin JR, Claridge TDW, Talbot K, Sibson NR, Turner MR. The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotempor Degenerat. 2015;16:456&#x2013;463. doi: 10.3109/21678421.2015.1053490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1053490</ArticleId><ArticleId IdType="pmc">PMC4720042</ArticleId><ArticleId IdType="pubmed">26121274</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, et al. ANG mutations segregate with familial and &#x2018;sporadic&#x2019; amyotrophic lateral sclerosis. Nat Genet. 2006;38:411&#x2013;413. doi: 10.1038/ng1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1742</ArticleId><ArticleId IdType="pubmed">16501576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha JS, Lee CS, Maeng JS, Kwon KS, Park SS. Chronic glutamate toxicity in mouse cortical neuron culture. Brain Res. 2009;1273:138&#x2013;143. doi: 10.1016/j.brainres.2009.03.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.03.050</ArticleId><ArticleId IdType="pubmed">19344697</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas R, Cucchi D, Smith J, Pucino V, Macdougall CE, Mauro C. Intermediates of metabolism: from bystanders to signalling molecules. Trends Biochem Sci. 2016;41:460&#x2013;471. doi: 10.1016/j.tibs.2016.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2016.02.003</ArticleId><ArticleId IdType="pubmed">26935843</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17085. doi: 10.1038/nrdp.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi N, Doi H, Kurata Y, Kagawa H, Atobe Y, Funakoshi K, Tada M, Katsumoto A, Tanaka K, Kunii M, et al. Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients. Neurosci Res. 2019 doi: 10.1016/j.neures.2019.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2019.10.010</ArticleId><ArticleId IdType="pubmed">31669371</ArticleId></ArticleIdList></Reference><Reference><Citation>Hladky SB, Barrand MA. Metabolite clearance during wakefulness and sleep. Handb Exp Pharmacol. 2019;253:385&#x2013;423. doi: 10.1007/164_2017_37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/164_2017_37</ArticleId><ArticleId IdType="pubmed">28744585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollinger SK, Okosun IS, Mitchell CS. Antecedent disease and amyotrophic lateral sclerosis: what is protecting whom? Front Neurol. 2016;7:47. doi: 10.3389/fneur.2016.00047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2016.00047</ArticleId><ArticleId IdType="pmc">PMC4810157</ArticleId><ArticleId IdType="pubmed">27065942</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) Proc Natl Acad Sci USA. 2002;99:1604&#x2013;1609. doi: 10.1073/pnas.032539299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.032539299</ArticleId><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, Kawai K, Takagi S, Yoshida M, Katsuno M, et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139:3187&#x2013;3201. doi: 10.1093/brain/aww237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff JJ, Wang M, Zeppenfeld DM, Venkataraman A, Plog BA, Liao Y, Deane R, Nedergaard M. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci. 2013;33:18190&#x2013;18199. doi: 10.1523/JNEUROSCI.1592-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1592-13.2013</ArticleId><ArticleId IdType="pmc">PMC3866416</ArticleId><ArticleId IdType="pubmed">24227727</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff JJ, Wang MH, Liao YH, Plogg BA, Peng WG, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, et al. A paravascular pathway facilitates CSF Flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4:147ra111. doi: 10.1126/scitranslmed.3003748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3003748</ArticleId><ArticleId IdType="pmc">PMC3551275</ArticleId><ArticleId IdType="pubmed">22896675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilzecka J, Stelmasiak Z, Dobosz B. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis. Cytokine. 2002;20:239&#x2013;243. doi: 10.1006/cyto.2002.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cyto.2002.2005</ArticleId><ArticleId IdType="pubmed">12550109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa T, Morita M, Nakano I. Constant blood flow reduction in premotor frontal lobe regions in ALS with dementia - a SPECT study with 3D-SSP. Acta Neurol Scand. 2007;116:340&#x2013;344. doi: 10.1111/j.1600-0404.2007.00876.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2007.00876.x</ArticleId><ArticleId IdType="pubmed">17922728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, Hitomi J, Zhu H, Chen H, Mayo L, et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science. 2016;353:603&#x2013;608. doi: 10.1126/science.aaf6803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaprakash K, Glasmacher SA, Pang B, Beswick E, Mehta AR, Dakin R, Newton J, Chandran S, Pal S, Colville S, et al. Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland. J Neurol. 2020;267:2459&#x2013;2461. doi: 10.1007/s00415-020-09919-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09919-9</ArticleId><ArticleId IdType="pmc">PMC7359150</ArticleId><ArticleId IdType="pubmed">32447548</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, Simpson E, Appel SH, York MK, Schulz PE. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010;17:733&#x2013;739. doi: 10.1111/j.1468-1331.2009.02923.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02923.x</ArticleId><ArticleId IdType="pubmed">20074230</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic system: a beginner&#x2019;s guide. Neurochem Res. 2015;40:2583&#x2013;2599. doi: 10.1007/s11064-015-1581-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-015-1581-6</ArticleId><ArticleId IdType="pmc">PMC4636982</ArticleId><ArticleId IdType="pubmed">25947369</ArticleId></ArticleIdList></Reference><Reference><Citation>Johanson CE, Duncan JA, 3rd, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res. 2008;5:10. doi: 10.1186/1743-8454-5-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-8454-5-10</ArticleId><ArticleId IdType="pmc">PMC2412840</ArticleId><ArticleId IdType="pubmed">18479516</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston M, Zakharov A, Papaiconomou C, Salmasi G, Armstrong D. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res. 2004;1:2. doi: 10.1186/1743-8454-1-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-8454-1-2</ArticleId><ArticleId IdType="pmc">PMC546409</ArticleId><ArticleId IdType="pubmed">15679948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabuta T, Suzuki Y, Wada K. Degradation of amyotrophic lateral sclerosis-linked mutant Cu, Zn-superoxide dismutase proteins by macroautophagy and the proteasome. J Biol Chem. 2006;281:30524&#x2013;30533. doi: 10.1074/jbc.M603337200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M603337200</ArticleId><ArticleId IdType="pubmed">16920710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanouchi T, Ohkubo T, Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? J Neurol Neurosur Ps. 2012;83:739&#x2013;745. doi: 10.1136/jnnp-2011-301826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301826</ArticleId><ArticleId IdType="pmc">PMC3368493</ArticleId><ArticleId IdType="pubmed">22544947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature. 2004;427:801. doi: 10.1038/427801a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/427801a</ArticleId><ArticleId IdType="pubmed">14985749</ArticleId></ArticleIdList></Reference><Reference><Citation>King AE, Woodhouse A, Kirkcaldie MT, Vickers JC. Excitotoxicity in ALS: overstimulation, or overreaction? Exp Neurol. 2016;275(Pt 1):162&#x2013;171. doi: 10.1016/j.expneurol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiviniemi V, Wang X, Korhonen V, Keinanen T, Tuovinen T, Autio J, LeVan P, Keilholz S, Zang YF, Hennig J, et al. Ultra-fast magnetic resonance encephalography of physiological brain activity&#x2014;glymphatic pulsation mechanisms? J Cereb Blood Flow Metab. 2016;36:1033&#x2013;1045. doi: 10.1177/0271678x15622047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678x15622047</ArticleId><ArticleId IdType="pmc">PMC4908626</ArticleId><ArticleId IdType="pubmed">26690495</ArticleId></ArticleIdList></Reference><Reference><Citation>Korner S, Kollewe K, Ilsemann J, Muller-Heine A, Dengler R, Krampfl K, Petri S. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol. 2013;20:E647&#x2013;E652. doi: 10.1111/ene.12015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12015</ArticleId><ArticleId IdType="pubmed">23094606</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, Xie L, Kang H, Xu Q, Liew JA, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014;76:845&#x2013;861. doi: 10.1002/ana.24271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24271</ArticleId><ArticleId IdType="pmc">PMC4245362</ArticleId><ArticleId IdType="pubmed">25204284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhnlein P, Gdynia HJ, Sperfeld AD, Lindner-Pfleghar B, Ludolph AC, Prosiegel M, Riecker A. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol. 2008;4:366&#x2013;374. doi: 10.1038/ncpneuro0853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneuro0853</ArticleId><ArticleId IdType="pubmed">18560390</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L, Doppler V, Beucler I, Costes G, Salachas F, Raisonnier A, Le Forestier N, Pradat PF, Bruckert E, Meininger V. APOE: a potential marker of disease progression in ALS. Neurology. 2002;58:1112&#x2013;1114. doi: 10.1212/Wnl.58.7.1112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/Wnl.58.7.1112</ArticleId><ArticleId IdType="pubmed">11940705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003;34:383&#x2013;394. doi: 10.1038/ng1211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1211</ArticleId><ArticleId IdType="pubmed">12847526</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Xie L, Yu M, Kang H, Feng T, Deane R, Logan J, Nedergaard M, Benveniste H. The effect of body posture on brain glymphatic transport. J Neurosci. 2015;35:11034&#x2013;11044. doi: 10.1523/JNEUROSCI.1625-15.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1625-15.2015</ArticleId><ArticleId IdType="pmc">PMC4524974</ArticleId><ArticleId IdType="pubmed">26245965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Zhang P, Kim HJ, Mitrea DM, Sarkar M, Freibaum BD, Cika J, Coughlin M, Messing J, Molliex A, et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167(774&#x2013;788):e717. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibiger C, Deisel J, Aufschnaiter A, Ambros S, Tereshchenko M, Verheijen BM, Buttner S, Braun RJ. Endolysosomal pathway activity protects cells from neurotoxic TDP-43. Microb Cell. 2018;5:212&#x2013;214. doi: 10.15698/mic2018.04.627.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/mic2018.04.627</ArticleId><ArticleId IdType="pmc">PMC5878689</ArticleId><ArticleId IdType="pubmed">29611555</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi A, Abbruzzese G, Arata L, Cocito L, Vische M. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis. J Neurol. 1984;231:75&#x2013;78. doi: 10.1007/bf00313720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00313720</ArticleId><ArticleId IdType="pubmed">6737012</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewerenz J, Maher P. Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence? Front Neurosci-Switz. 2015;9:469. doi: 10.3389/fnins.2015.00469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00469</ArticleId><ArticleId IdType="pmc">PMC4679930</ArticleId><ArticleId IdType="pubmed">26733784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilius TO, Blomqvist K, Hauglund NL, Liu G, Staeger FF, Baerentzen S, Du T, Ahlstrom F, Backman JT, Kalso EA, et al. Dexmedetomidine enhances glymphatic brain delivery of intrathecally administered drugs. J Control Release. 2019;304:29&#x2013;38. doi: 10.1016/j.jconrel.2019.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2019.05.005</ArticleId><ArticleId IdType="pubmed">31067483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin FC, Tsai CP, Lee JKW, Wu MT, Lee CTC. Angiotensin-converting enzyme inhibitors and amyotrophic lateral sclerosis risk: a total population-based case-control study. Jama Neurol. 2015;72:40&#x2013;48. doi: 10.1001/jamaneurol.2014.3367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.3367</ArticleId><ArticleId IdType="pubmed">25383557</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Coyne AN, Pei F, Vaughan S, Chaung M, Zarnescu DC, Buchan JR. Endocytosis regulates TDP-43 toxicity and turnover. Nat Commun. 2017;8:2092. doi: 10.1038/s41467-017-02017-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02017-x</ArticleId><ArticleId IdType="pmc">PMC5727062</ArticleId><ArticleId IdType="pubmed">29233983</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A, Plog BA, Antila S, Alitalo K, Nedergaard M, Kipnis J. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest. 2017;127:3210&#x2013;3219. doi: 10.1172/JCI90603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90603</ArticleId><ArticleId IdType="pmc">PMC5669566</ArticleId><ArticleId IdType="pubmed">28862640</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337&#x2013;341. doi: 10.1038/nature14432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14432</ArticleId><ArticleId IdType="pmc">PMC4506234</ArticleId><ArticleId IdType="pubmed">26030524</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgaard I, Lu ML, Yang E, Peng W, Mestre H, Hitomi E, Deane R, Nedergaard M. Glymphatic clearance controls state-dependent changes in brain lactate concentration. J Cereb Blood Flow Metab. 2017;37:2112&#x2013;2124. doi: 10.1177/0271678X16661202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X16661202</ArticleId><ArticleId IdType="pmc">PMC5464705</ArticleId><ArticleId IdType="pubmed">27481936</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, Diczfalusy U, Bjorkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA. 1996;93:9799&#x2013;9804. doi: 10.1073/pnas.93.18.9799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.18.9799</ArticleId><ArticleId IdType="pmc">PMC38509</ArticleId><ArticleId IdType="pubmed">8790411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma QL, Ineichen BV, Detmar M, Proulx ST. Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice. Nat Commun. 2017;8:1434. doi: 10.1038/s41467-017-01484-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01484-6</ArticleId><ArticleId IdType="pmc">PMC5681558</ArticleId><ArticleId IdType="pubmed">29127332</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo AC, Balouch S, Tabet N. Is sleep disruption a risk factor for Alzheimer&#x2019;s disease? J Alzheimers Dis. 2017;58:993&#x2013;1002. doi: 10.3233/jad-161287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-161287</ArticleId><ArticleId IdType="pubmed">28550253</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chio A, Restagno G, Nicolaou N, Simon-Sanchez J, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder V, Gregory JM, Barria MA, Green A, Pal S. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. BMC Neurol. 2018;18:90. doi: 10.1186/s12883-018-1091-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1091-7</ArticleId><ArticleId IdType="pmc">PMC6027783</ArticleId><ArticleId IdType="pubmed">29954341</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, Ferri L, Fasano A, Zucchi E, Fini N, Moglia C, Lunetta C, Marinou K, Ticozzi N, Ferrante GD, et al. Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis. Eur J Neurol. 2018;25:861&#x2013;868. doi: 10.1111/ene.13620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13620</ArticleId><ArticleId IdType="pubmed">29512869</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, Janssen A, Dougherty A, Willey E, Stanton BR, et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler. 2010;11:439&#x2013;442. doi: 10.3109/17482961003610853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003610853</ArticleId><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Kamel F, Bellocco R, Ye W, Fang F. Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur J Neurol. 2015;22:1436&#x2013;1442. doi: 10.1111/ene.12632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12632</ArticleId><ArticleId IdType="pmc">PMC4506907</ArticleId><ArticleId IdType="pubmed">25600257</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta AR, Walters R, Waldron FM, Pal S, Selvaraj BT, Macleod MR, Hardingham GE, Chandran S, Gregory JM. Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Brain Commun. 2019;1:fcz009. doi: 10.1093/braincomms/fcz009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcz009</ArticleId><ArticleId IdType="pmc">PMC7056361</ArticleId><ArticleId IdType="pubmed">32133457</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y, Abrahao A, Heyn CC, Bethune AJ, Huang Y, Pople CB, Aubert I, Hamani C, Zinman L, Hynynen K, et al. Glymphatics visualization after focused ultrasound-induced blood-brain barrier opening in humans. Ann Neurol. 2019;86:975&#x2013;980. doi: 10.1002/ana.25604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25604</ArticleId><ArticleId IdType="pubmed">31525269</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestre H, Hablitz LM, Xavier ALR, Feng WX, Zou WY, Pu TL, Monai H, Murlidharan G, Rivera RMC, Simon MJ, et al. Aquaporin-4-dependent glymphatic solute transport in the rodent brain. Elife. 2018;7:e40070. doi: 10.7554/eLife.40070.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.40070</ArticleId><ArticleId IdType="pmc">PMC6307855</ArticleId><ArticleId IdType="pubmed">30561329</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestre H, Tithof J, Du T, Song W, Peng W, Sweeney AM, Olveda G, Thomas JH, Nedergaard M, Kelley DH. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nat Commun. 2018;9:4878. doi: 10.1038/s41467-018-07318-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07318-3</ArticleId><ArticleId IdType="pmc">PMC6242982</ArticleId><ArticleId IdType="pubmed">30451853</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TM, Pestronk A, David W, Rothstein J, Simpson E, Appel SH, Andres PL, Mahoney K, Allred P, Alexander K, et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol. 2013;12:435&#x2013;442. doi: 10.1016/S1474-4422(13)70061-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70061-9</ArticleId><ArticleId IdType="pmc">PMC3712285</ArticleId><ArticleId IdType="pubmed">23541756</ArticleId></ArticleIdList></Reference><Reference><Citation>Milosevic M, Milicevic K, Bozic I, Lavrnja I, Stevanovic I, Bijelic D, Dubaic M, Zivkovic I, Stevic Z, Giniatullin R, et al. Immunoglobulins G from sera of amyotrophic lateral sclerosis patients induce oxidative stress and upregulation of antioxidative system in BV-2 microglial cell line. Front Immunol. 2017;8:1619. doi: 10.3389/fimmu.2017.01619.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01619</ArticleId><ArticleId IdType="pmc">PMC5703705</ArticleId><ArticleId IdType="pubmed">29218049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Boutej H, Soucy G, Bareil C, Kumar S, Picher-Martel V, Dupre N, Kriz J, Julien JP. Transmission of ALS pathogenesis by the cerebrospinal fluid. Acta Neuropathol Commun. 2020;8:65. doi: 10.1186/s40478-020-00943-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00943-4</ArticleId><ArticleId IdType="pmc">PMC7206749</ArticleId><ArticleId IdType="pubmed">32381112</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Dhull DK, Nalini A, Vijayalakshmi K, Sathyaprabha TN, Alladi PA, Raju TR. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients. J Neuroinflammation. 2016;13:212. doi: 10.1186/s12974-016-0698-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0698-0</ArticleId><ArticleId IdType="pmc">PMC5006495</ArticleId><ArticleId IdType="pubmed">27578023</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Vijayalakshmi K, Nalini A, Sathyaprabha TN, Kramer BW, Alladi PA, Raju TR. Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia. J Neuroinflam. 2017;14:251. doi: 10.1186/s12974-017-1028-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-1028-x</ArticleId><ArticleId IdType="pmc">PMC5732516</ArticleId><ArticleId IdType="pubmed">29246232</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Canosa A, Bertuzzo D, Cugnasco P, Solero L, Grassano M, Bersano E, Cammarosano S, Manera U, et al. Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study. Amyotroph Lateral Scler Frontotempor Degenerat. 2017;18:590&#x2013;597. doi: 10.1080/21678421.2017.1336560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1336560</ArticleId><ArticleId IdType="pubmed">28616937</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C, Brunaud-Danel V, Dallongeville J, Duhamel A, Laurier-Grymonprez L, de Reuck J, Wiart AC, Perez T, Richard F, Amouyel P, et al. Modifying effect of arterial hypertension on amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:194&#x2013;201. doi: 10.3109/17482968.2011.610110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.610110</ArticleId><ArticleId IdType="pubmed">21913867</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C, Devos D, Brunaud-Danel V, Defebvre L, Perez T, Destee A, Tonnel AB, Lassalle P, Just N. Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology. 2005;65:1958&#x2013;1960. doi: 10.1212/01.wnl.0000188907.97339.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000188907.97339.76</ArticleId><ArticleId IdType="pubmed">16380619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortensen KN, Sanggaard S, Mestre H, Lee H, Kostrikov S, Xavier ALR, Gjedde A, Benveniste H, Nedergaard M. Impaired glymphatic transport in spontaneously hypertensive rats. J Neurosci. 2019;39:6365&#x2013;6377. doi: 10.1523/JNEUROSCI.1974-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1974-18.2019</ArticleId><ArticleId IdType="pmc">PMC6687896</ArticleId><ArticleId IdType="pubmed">31209176</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C, O&#x2019;Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci USA. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Murtha LA, Yang Q, Parsons MW, Levi CR, Beard DJ, Spratt NJ, McLeod DD. Cerebrospinal fluid is drained primarily via the spinal canal and olfactory route in young and aged spontaneously hypertensive rats. Fluids Barriers CNS. 2014;11:12. doi: 10.1186/2045-8118-11-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-11-12</ArticleId><ArticleId IdType="pmc">PMC4057524</ArticleId><ArticleId IdType="pubmed">24932405</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedergaard M, Goldman SA, Desai S, Pulsinelli WA. Acid-induced death in neurons and glia. J Neurosci. 1991;11:2489&#x2013;2497. doi: 10.1523/JNEUROSCI.11-08-02489.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.11-08-02489.1991</ArticleId><ArticleId IdType="pmc">PMC6575492</ArticleId><ArticleId IdType="pubmed">1869926</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Kee Kwong KC, Gregory JM, Pal S, Chandran S, Mehta AR, Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of&#xa0;in vitro studies, Brain Communications, fcaa121. 10.1093/braincomms/fcaa12</Citation></Reference><Reference><Citation>Nicaise C, Soyfoo MS, Authelet M, De Decker R, Bataveljic D, Delporte C, Pochet R. Aquaporin-4 overexpression in rat ALS model. Anat Rec (Hoboken) 2009;292:207&#x2013;213. doi: 10.1002/ar.20838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.20838</ArticleId><ArticleId IdType="pubmed">19089902</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccoli T, Partridge L, Isaacs AM. Ageing as a risk factor for ALS/FTD. Hum Mol Genet. 2017;26:R105&#x2013;R113. doi: 10.1093/hmg/ddx247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx247</ArticleId><ArticleId IdType="pubmed">28977441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Talbot K, Ansorge O. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models. Acta Neuropathol Commun. 2016;4:99. doi: 10.1186/s40478-016-0358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0358-8</ArticleId><ArticleId IdType="pmc">PMC5011941</ArticleId><ArticleId IdType="pubmed">27600654</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura T, Watanabe S, Kaneko K, Yamanaka K, Nukina N, Furukawa Y. Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis. J Biol Chem. 2014;289:1192&#x2013;1202. doi: 10.1074/jbc.M113.516492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.516492</ArticleId><ArticleId IdType="pmc">PMC3887186</ArticleId><ArticleId IdType="pubmed">24280224</ArticleId></ArticleIdList></Reference><Reference><Citation>Obal I, Jakab JS, Siklos L, Engelhardt JI. Recruitment of activated microglia cells in the spinal cord of mice by ALS IgG. NeuroReport. 2001;12:2449&#x2013;2452. doi: 10.1097/00001756-200108080-00032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200108080-00032</ArticleId><ArticleId IdType="pubmed">11496127</ArticleId></ArticleIdList></Reference><Reference><Citation>Obal I, Klausz G, Mandi Y, Deli M, Siklos L, Engelhardt JI. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-alpha, IL-6, and IL-10 in the spinal cord and serum of mice. J Neuroinflamm. 2016;13:121. doi: 10.1186/s12974-016-0586-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0586-7</ArticleId><ArticleId IdType="pmc">PMC4879728</ArticleId><ArticleId IdType="pubmed">27220674</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh KW, Moon C, Kim HY, Oh SI, Park J, Lee JH, Chang IY, Kim KS, Kim SH. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Stem Cells Transl Med. 2015;4:590&#x2013;597. doi: 10.5966/sctm.2014-0212.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2014-0212</ArticleId><ArticleId IdType="pmc">PMC4449093</ArticleId><ArticleId IdType="pubmed">25934946</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh KW, Noh MY, Kwon MS, Kim HY, Oh SI, Park J, Kim HJ, Ki CS, Kim SH. Repeated intrathecal mesenchymal stem cells for amyotrophic lateral sclerosis. Ann Neurol. 2018;84:361&#x2013;373. doi: 10.1002/ana.25302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25302</ArticleId><ArticleId IdType="pmc">PMC6175096</ArticleId><ArticleId IdType="pubmed">30048006</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001;28:131&#x2013;138. doi: 10.1038/88842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/88842</ArticleId><ArticleId IdType="pubmed">11381259</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Kriz J, Gravel M, Soucy G, Bareil C, Gravel C, Julien JP. Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis. Mol Therapy. 2014;22:498&#x2013;510. doi: 10.1038/mt.2013.239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.239</ArticleId><ArticleId IdType="pmc">PMC3944333</ArticleId><ArticleId IdType="pubmed">24394188</ArticleId></ArticleIdList></Reference><Reference><Citation>Paubel A, Violette J, Amy M, Praline J, Meininger V, Camu W, Corcia P, Andres CR, Vourc&#x2019;h P, French Amyotrophic Lateral Sclerosis Study G Mutations of the ANG gene in French patients with sporadic amyotrophic lateral sclerosis. Arch Neurol. 2008;65:1333&#x2013;1336. doi: 10.1001/archneur.65.10.1333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.10.1333</ArticleId><ArticleId IdType="pubmed">18852347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol. 1994;51:874&#x2013;887. doi: 10.1001/archneur.1994.00540210046012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1994.00540210046012</ArticleId><ArticleId IdType="pubmed">8080387</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Rothstein JD. Glial cells in amyotrophic lateral sclerosis. Exp Neurol. 2014;262:111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Plog BA, Mestre H, Olveda GE, Sweeney AM, Kenney HM, Cove A, Dholakia KY, Tithof J, Nevins TD, Lundgaard I, et al. Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain. JCI Insight. 2018 doi: 10.1172/jci.insight.126138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.126138</ArticleId><ArticleId IdType="pmc">PMC6328017</ArticleId><ArticleId IdType="pubmed">30518698</ArticleId></ArticleIdList></Reference><Reference><Citation>Plog BA, Nedergaard M. The glymphatic system in central nervous system health and disease: past, present, and future. Annu Rev Pathol Mech. 2018;13:379&#x2013;394. doi: 10.1146/annurev-pathol-051217-111018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-051217-111018</ArticleId><ArticleId IdType="pmc">PMC5803388</ArticleId><ArticleId IdType="pubmed">29195051</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, Grad L, Cashman N. Misfolded wild-type SOD1 induced by pathological FUS or TDP-43 transmits intercellularly and is propagation-competent. Prion. 2015;9:S7&#x2013;S8.</Citation></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Preston JE. Ageing choroid plexus-cerebrospinal fluid system. Microsc Res Techn. 2001;52:31&#x2013;37. doi: 10.1002/1097-0029(20010101)52:1&lt;31::AID-JEMT5&gt;3.0.CO;2-T.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0029(20010101)52:1&lt;31::AID-JEMT5&gt;3.0.CO;2-T</ArticleId><ArticleId IdType="pubmed">11135446</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen AH, Demestre M, Howard RS, Orrell RW. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2&#x2009;+&#x2009;enhancement. Acta Neuropathol. 2004;107:35&#x2013;46. doi: 10.1007/s00401-003-0777-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-003-0777-z</ArticleId><ArticleId IdType="pubmed">14551798</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen AH, Humphreys P. Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls. J Neurol Sci. 2000;180:35&#x2013;45. doi: 10.1016/s0022-510x(00)00427-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(00)00427-5</ArticleId><ArticleId IdType="pubmed">11090862</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaranta VN, Carratu P, Damiani MF, Dragonieri S, Capozzolo A, Cassano A, Resta O. The prognostic role of obstructive sleep apnea at the onset of amyotrophic lateral sclerosis. Neurodegener Dis. 2017;17:14&#x2013;21. doi: 10.1159/000447560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000447560</ArticleId><ArticleId IdType="pubmed">27595268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramamohan PY, Gourie-Devi M, Nalini A, Shobha K, Ramamohan Y, Joshi P, Raju TR. Cerebrospinal fluid from amyotrophic lateral sclerosis patients causes fragmentation of the Golgi apparatus in the neonatal rat spinal cord. Amyotroph Lateral Scler. 2007;8:79&#x2013;82. doi: 10.1080/08037060601145489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08037060601145489</ArticleId><ArticleId IdType="pubmed">17453633</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangroo Thrane V, Thrane AS, Plog BA, Thiyagarajan M, Iliff JJ, Deane R, Nagelhus EA, Nedergaard M. Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain. Sci Rep. 2013;3:2582. doi: 10.1038/srep02582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep02582</ArticleId><ArticleId IdType="pmc">PMC3761080</ArticleId><ArticleId IdType="pubmed">24002448</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao MS, Devi MG, Nalini A, Shahani N, Raju TR. Neurofilament phosphorylation is increased in ventral horn neurons of neonatal rat spinal cord exposed to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Neurodegeneration. 1995;4:397&#x2013;401. doi: 10.1006/neur.1995.0048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/neur.1995.0048</ArticleId><ArticleId IdType="pubmed">8846233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;811. doi: 10.1212/WNL.0b013e3181b6bbbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Rennels ML, Gregory TF, Blaumanis OR, Fujimoto K, Grady PA. Evidence for a paravascular fluid circulation in the mammalian central nervous-system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 1985;326:47&#x2013;63. doi: 10.1016/0006-8993(85)91383-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(85)91383-6</ArticleId><ArticleId IdType="pubmed">3971148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain. 2017;140:2691&#x2013;2705. doi: 10.1093/brain/awx191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx191</ArticleId><ArticleId IdType="pmc">PMC5841149</ArticleId><ArticleId IdType="pubmed">28969373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995;38:73&#x2013;84. doi: 10.1002/ana.410380114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380114</ArticleId><ArticleId IdType="pubmed">7611729</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankaranarayani R, Nalini A, Laxmi TR, Raju TR. Altered neuronal activities in the motor cortex with impaired motor performance in adult rats observed after infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients. Behav Brain Res. 2010;206:109&#x2013;119. doi: 10.1016/j.bbr.2009.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2009.09.009</ArticleId><ArticleId IdType="pubmed">19747511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartoretti T, Wyss M, Sartoretti E, Reischauer C, Hainc N, Graf N, Binkert C, Najafi A, Sartoretti-Schefer S. Sex and age dependencies of aqueductal cerebrospinal fluid dynamics parameters in healthy subjects. Front Aging Neurosci. 2019;11:199. doi: 10.3389/fnagi.2019.00199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00199</ArticleId><ArticleId IdType="pmc">PMC6688190</ArticleId><ArticleId IdType="pubmed">31427956</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Komori T, Iwata M. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol. 2000;100:138&#x2013;144. doi: 10.1007/s004019900159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004019900159</ArticleId><ArticleId IdType="pubmed">10963360</ArticleId></ArticleIdList></Reference><Reference><Citation>Sass LR, Khani M, Romm J, Schmid Daners M, McCain K, Freeman T, Carter GT, Weeks DL, Petersen B, Aldred J, et al. Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients. Fluids Barriers CNS. 2020;17:4. doi: 10.1186/s12987-019-0164-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-019-0164-3</ArticleId><ArticleId IdType="pmc">PMC6971921</ArticleId><ArticleId IdType="pubmed">31959193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, Morimoto N, Matsuura T, Ohta Y, Tsunoda M, Ikeda Y, Abe K. CSF flow dynamics in motor neuron disease. Neurol Res. 2012;34:512&#x2013;517. doi: 10.1179/1743132812Y.0000000043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132812Y.0000000043</ArticleId><ArticleId IdType="pubmed">22664138</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid Daners M, Knobloch V, Soellinger M, Boesiger P, Seifert B, Guzzella L, Kurtcuoglu V. Age-specific characteristics and coupling of cerebral arterial inflow and cerebrospinal fluid dynamics. PLoS ONE. 2012;7:e37502. doi: 10.1371/journal.pone.0037502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037502</ArticleId><ArticleId IdType="pmc">PMC3364266</ArticleId><ArticleId IdType="pubmed">22666360</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekiguchi T, Kanouchi T, Shibuya K, Noto Y, Yagi Y, Inaba A, Abe K, Misawa S, Orimo S, Kobayashi T, et al. Spreading of amyotrophic lateral sclerosis lesions&#x2013;multifocal hits and local propagation? J Neurol Neurosurg Psychiatry. 2014;85:85&#x2013;91. doi: 10.1136/jnnp-2013-305617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-305617</ArticleId><ArticleId IdType="pubmed">24027298</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekizawa T, Openshaw H, Ohbo K, Sugamura K, Itoyama Y, Niland JC. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J Neurol Sci. 1998;154:194&#x2013;199. doi: 10.1016/s0022-510x(97)00228-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(97)00228-1</ArticleId><ArticleId IdType="pubmed">9562310</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmukha S, Narayanappa G, Nalini A, Alladi PA, Raju TR. Sporadic amyotrophic lateral sclerosis (SALS)&#x2014;skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model. Dis Model Mech. 2018 doi: 10.1242/dmm.031997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.031997</ArticleId><ArticleId IdType="pmc">PMC5963857</ArticleId><ArticleId IdType="pubmed">29666144</ArticleId></ArticleIdList></Reference><Reference><Citation>Shantanu S, Vijayalakshmi K, Shruthi S, Sagar BKC, Sathyaprabha TN, Nalini A, Raju TR, Alladi PA. VEGF alleviates ALS-CSF induced cytoplasmic accumulations of TDP-43 and FUS/TLS in NSC-34 cells. J Chem Neuroanat. 2017;81:48&#x2013;52. doi: 10.1016/j.jchemneu.2017.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2017.01.007</ArticleId><ArticleId IdType="pubmed">28163215</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Varghese AM, Vijaylakshmi K, Sumitha R, Prasanna VK, Shruthi S, Sagar BKC, Datta KK, Gowda H, Nalini A, et al. Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces mitochondrial and lysosomal dysfunction. Neurochem Res. 2016;41:965&#x2013;984. doi: 10.1007/s11064-015-1779-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-015-1779-7</ArticleId><ArticleId IdType="pubmed">26646005</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ. Toxicity of CSF in motor neurone disease: a potential route to neuroprotection. Brain. 2002;125:693&#x2013;694. doi: 10.1093/brain/awf138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awf138</ArticleId><ArticleId IdType="pubmed">11912105</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D, Hou B, Xu Y, Cui B, Peng P, Li X, Tai H, Zhang K, Liu S, Fu H, et al. Brain structural and perfusion signature of amyotrophic lateral sclerosis with varying levels of cognitive deficit. Front Neurol. 2018;9:364. doi: 10.3389/fneur.2018.00364.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00364</ArticleId><ArticleId IdType="pmc">PMC5976730</ArticleId><ArticleId IdType="pubmed">29881369</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim HG, Jang SS, Kim SH, Hwang EM, Min JO, Kim HY, Kim YS, Ryu C, Chung G, Kim Y, et al. TNF-alpha increases the intrinsic excitability of cerebellar Purkinje cells through elevating glutamate release in Bergmann Glia. Sci Rep UK. 2018;8:11589. doi: 10.1038/s41598-018-29786-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-29786-9</ArticleId><ArticleId IdType="pmc">PMC6072779</ArticleId><ArticleId IdType="pubmed">30072733</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobha K, Vijayalakshmi K, Alladi PA, Nalini A, Sathyaprabha TN, Raju TR. Altered in vitro and in vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J Neurol Sci. 2007;254:9&#x2013;16. doi: 10.1016/j.jns.2006.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.12.004</ArticleId><ArticleId IdType="pubmed">17254611</ArticleId></ArticleIdList></Reference><Reference><Citation>Shokri-Kojori E, Wang GJ, Wiers CE, Demiral SB, Guo M, Kim SW, Lindgren E, Ramirez V, Zehra A, Freeman C, et al. beta-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci USA. 2018;115:4483&#x2013;4488. doi: 10.1073/pnas.1721694115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1721694115</ArticleId><ArticleId IdType="pmc">PMC5924922</ArticleId><ArticleId IdType="pubmed">29632177</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AJ, Yao XM, Dix JA, Jin BJ, Verkman AS. Test of the &#x2018;glymphatic&#x2019; hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma. Elife. 2017 doi: 10.7554/elife.27679.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/elife.27679</ArticleId><ArticleId IdType="pmc">PMC5578736</ArticleId><ArticleId IdType="pubmed">28826498</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R, Myers K, Ravits J, Bowser R. Amyotrophic lateral sclerosis: is the spinal fluid pathway involved in seeding and spread? Med Hypotheses. 2015;85:576&#x2013;583. doi: 10.1016/j.mehy.2015.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2015.07.014</ArticleId><ArticleId IdType="pubmed">26220261</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RG, Henry YK, Mattson MP, Appel SH. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol. 1998;44:696&#x2013;699. doi: 10.1002/ana.410440419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440419</ArticleId><ArticleId IdType="pubmed">9778272</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen TT, Horvath-Puho E, Norgaard M, Ehrenstein V, Henderson VW. Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study. BMJ Open. 2019 doi: 10.1136/bmjopen-2019-030015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-030015</ArticleId><ArticleId IdType="pmc">PMC6615877</ArticleId><ArticleId IdType="pubmed">31278107</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, Marouan A, Dib M, Meininger V. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci. 2002;193:73&#x2013;78. doi: 10.1016/s0022-510x(01)00661-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(01)00661-x</ArticleId><ArticleId IdType="pubmed">11790386</ArticleId></ArticleIdList></Reference><Reference><Citation>Staff NP, Madigan NN, Morris J, Jentoft M, Sorenson EJ, Butler G, Gastineau D, Dietz A, Windebank AJ. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS. Neurology. 2016;87:2230&#x2013;2234. doi: 10.1212/WNL.0000000000003359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003359</ArticleId><ArticleId IdType="pmc">PMC5123559</ArticleId><ArticleId IdType="pubmed">27784774</ArticleId></ArticleIdList></Reference><Reference><Citation>Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci. 2005;8:85&#x2013;92. doi: 10.1038/nn1360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1360</ArticleId><ArticleId IdType="pubmed">15568021</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM, Mollenhauer B, Schneider A. Induction of alpha-synuclein aggregate formation by CSF exosomes from patients with Parkinson&#x2019;s disease and dementia with Lewy bodies. Brain. 2016;139:481&#x2013;494. doi: 10.1093/brain/awv346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv346</ArticleId><ArticleId IdType="pmc">PMC4805087</ArticleId><ArticleId IdType="pubmed">26647156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumitha R, Manjunatha VM, Sabitha RK, Alladi PA, Nalini A, Rao LT, Chandrasekhar Sagar BK, Steinbusch HWM, Kramer BW, Sathyaprabha TN, et al. Cerebrospinal fluid from patients with sporadic amyotrophic lateral sclerosis induces degeneration of motor neurons derived from human embryonic stem cells. Mol Neurobiol. 2019;56:1014&#x2013;1034. doi: 10.1007/s12035-018-1149-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1149-y</ArticleId><ArticleId IdType="pubmed">29858777</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11:457&#x2013;470. doi: 10.1038/nrneurol.2015.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.119</ArticleId><ArticleId IdType="pmc">PMC4694579</ArticleId><ArticleId IdType="pubmed">26195256</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol. 1999;46:129&#x2013;131. doi: 10.1002/1531-8249(199907)46:1&lt;129::aid-ana21&gt;3.0.co;2-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199907)46:1&lt;129::aid-ana21&gt;3.0.co;2-y</ArticleId><ArticleId IdType="pubmed">10401792</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci. 2006;9:108&#x2013;118. doi: 10.1038/nn1603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1603</ArticleId><ArticleId IdType="pubmed">16369483</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Robberecht W. Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery. Exp Opin Inv Drug. 2014;23:955&#x2013;963. doi: 10.1517/13543784.2014.912275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543784.2014.912275</ArticleId><ArticleId IdType="pubmed">24816247</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bosch L, Van Damme P, Bogaert E, Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. BBA Mol Basis Dis. 2006;1762:1068&#x2013;1082. doi: 10.1016/j.bbadis.2006.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.002</ArticleId><ArticleId IdType="pubmed">16806844</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Schelhaas HJ, van Vught PW, Ticozzi N, Andersen PM, Groen EJ, Schulte C, Blauw HM, Koppers M, Diekstra FP, et al. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol. 2011;70:964&#x2013;973. doi: 10.1002/ana.22611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22611</ArticleId><ArticleId IdType="pmc">PMC5560057</ArticleId><ArticleId IdType="pubmed">22190368</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K, Alladi PA, Ghosh S, Prasanna VK, Sagar BC, Nalini A, Sathyaprabha TN, Raju TR. Evidence of endoplasmic reticular stress in the spinal motor neurons exposed to CSF from sporadic amyotrophic lateral sclerosis patients. Neurobiol Dis. 2011;41:695&#x2013;705. doi: 10.1016/j.nbd.2010.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.12.005</ArticleId><ArticleId IdType="pubmed">21168498</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K, Alladi PA, Sathyaprabha TN, Subramaniam JR, Nalini A, Raju TR. Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line. Brain Res. 2009;1263:122&#x2013;133. doi: 10.1016/j.brainres.2009.01.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.01.041</ArticleId><ArticleId IdType="pubmed">19368830</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K, Ostwal P, Sumitha R, Shruthi S, Varghese AM, Mishra P, Manohari SG, Sagar BC, Sathyaprabha TN, Nalini A, et al. Role of VEGF and VEGFR2 receptor in reversal of ALS-CSF induced degeneration of NSC-34 motor neuron cell line. Mol Neurobiol. 2015;51:995&#x2013;1007. doi: 10.1007/s12035-014-8757-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8757-y</ArticleId><ArticleId IdType="pubmed">24880751</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldemar G, Vorstrup S, Jensen TS, Johnsen A, Boysen G. Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d, l-HMPAO SPECT study. J Neurol Sci. 1992;107:19&#x2013;28. doi: 10.1016/0022-510x(92)90204-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(92)90204-x</ArticleId><ArticleId IdType="pubmed">1578230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yang B, Qiu L, Yang C, Kramer J, Su Q, Guo Y, Brown RH, Jr, Gao G, Xu Z. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis. Hum Mol Genet. 2014;23:668&#x2013;681. doi: 10.1093/hmg/ddt454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt454</ArticleId><ArticleId IdType="pmc">PMC3888258</ArticleId><ArticleId IdType="pubmed">24108104</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Balaji V, Kaniyappan S, Kruger L, Irsen S, Tepper K, Chandupatla R, Maetzler W, Schneider A, Mandelkow E, et al. The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener. 2017;12:5. doi: 10.1186/s13024-016-0143-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0143-y</ArticleId><ArticleId IdType="pmc">PMC5237256</ArticleId><ArticleId IdType="pubmed">28086931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardlaw JM, Benveniste H, Nedergaard M, Zlokovic BV, Mestre H, Lee H, Doubal FN, Brown R, Ramirez J, MacIntosh BJ, et al. Perivascular spaces in the brain: anatomy, physiology and pathology. Nat Rev Neurol. 2020 doi: 10.1038/s41582-020-0312-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0312-z</ArticleId><ArticleId IdType="pubmed">32094487</ArticleId></ArticleIdList></Reference><Reference><Citation>Warita H, Manabe Y, Murakami T, Shiote M, Shiro Y, Hayashi T, Nagano I, Shoji M, Abe K. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1. Neurol Res. 2002;24:577&#x2013;581. doi: 10.1179/016164102101200384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164102101200384</ArticleId><ArticleId IdType="pubmed">12238624</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe-Matsumoto S, Moriwaki Y, Okuda T, Ohara S, Yamanaka K, Abe Y, Yasui M, Misawa H. Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis. Neurosci Res. 2018;133:48&#x2013;57. doi: 10.1016/j.neures.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.11.001</ArticleId><ArticleId IdType="pubmed">29154923</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Jensen BK, Wen XM, Cai JL, Kropf E, Iacovitti L, Pasinelli P, Trotti D. Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell Rep. 2016;17:645&#x2013;652. doi: 10.1016/j.celrep.2016.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.032</ArticleId><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolak DJ, Thorne RG. Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm. 2013;10:1492&#x2013;1504. doi: 10.1021/mp300495e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/mp300495e</ArticleId><ArticleId IdType="pmc">PMC3646902</ArticleId><ArticleId IdType="pubmed">23298378</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen A, Moritz T, Marklund SL, Antti H, Andersen PM. Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. PLoS ONE. 2011 doi: 10.1371/journal.pone.0017947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017947</ArticleId><ArticleId IdType="pmc">PMC3070699</ArticleId><ArticleId IdType="pubmed">21483737</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O&#x2019;Donnell J, Christensen DJ, Nicholson C, Iliff JJ, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342:373&#x2013;377. doi: 10.1126/science.1241224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1241224</ArticleId><ArticleId IdType="pmc">PMC3880190</ArticleId><ArticleId IdType="pubmed">24136970</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 2006;26:4985&#x2013;4994. doi: 10.1523/JNEUROSCI.5476-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5476-05.2006</ArticleId><ArticleId IdType="pmc">PMC6674234</ArticleId><ArticleId IdType="pubmed">16687490</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu ZW, Henderson RD, David M, McCombe PA. Neurofilaments as biomarkers for amyotrophic lateral sclerosis: a systematic review and meta-analysis. PLoS ONE. 2016 doi: 10.1371/journal.pone.0164625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0164625</ArticleId><ArticleId IdType="pmc">PMC5061412</ArticleId><ArticleId IdType="pubmed">27732645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S, Miyazaki M, Yamashita Y, Ouyang C, Yui M, Nakahashi M, Shimizu S, Aoki I, Morohoshi Y, McComb JG. Influence of respiration on cerebrospinal fluid movement using magnetic resonance spin labeling. Fluids Barriers CNS. 2013;10:36. doi: 10.1186/2045-8118-10-36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-10-36</ArticleId><ArticleId IdType="pmc">PMC3895787</ArticleId><ArticleId IdType="pubmed">24373186</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung C, Sha D, Li L, Chin LS. Parkin protects against misfolded SOD1 Toxicity By Promoting Its Aggresome Formation And Autophagic Clearance. Mol Neurobiol. 2016;53:6270&#x2013;6287. doi: 10.1007/s12035-015-9537-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9537-z</ArticleId><ArticleId IdType="pmc">PMC4866905</ArticleId><ArticleId IdType="pubmed">26563499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Jansen-West K, Xu YF, Gendron TF, Bieniek KF, Lin WL, Sasaguri H, Caulfield T, Hubbard J, Daughrity L, et al. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 2014;128:505&#x2013;524. doi: 10.1007/s00401-014-1336-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1336-5</ArticleId><ArticleId IdType="pmc">PMC4159567</ArticleId><ArticleId IdType="pubmed">25173361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Devlin AC, Chouhan AK, Selvaraj BT, Stavrou M, Burr K, Brivio V, He X, Mehta AR, Story D, et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2019 doi: 10.1002/glia.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O&#x2019;Banion MK, Stojanovic K, Sagare A, Boillee S, Cleveland DW, et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci. 2008;11:420&#x2013;422. doi: 10.1038/nn2073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2073</ArticleId><ArticleId IdType="pmc">PMC2895310</ArticleId><ArticleId IdType="pubmed">18344992</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Cai J, Zhang W, Gong X, Yan S, Zhang K, Luo Z, Sun J, Jiang Q, Lou M. Impairment of the glymphatic pathway and putative meningeal lymphatic vessels in the aging human. Ann Neurol. 2020;87:357&#x2013;369. doi: 10.1002/ana.25670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25670</ArticleId><ArticleId IdType="pubmed">31916277</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer&#x2019;s disease and other disorders. Nat Rev Neurosci. 2011;12:723&#x2013;738. doi: 10.1038/nrn3114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3114</ArticleId><ArticleId IdType="pmc">PMC4036520</ArticleId><ArticleId IdType="pubmed">22048062</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou JY, Crews FT. TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 2005;1034:11&#x2013;24. doi: 10.1016/j.brainres.2004.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.11.014</ArticleId><ArticleId IdType="pubmed">15713255</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou S, Lan YL, Wang HJ, Zhang B, Sun YG. The potential roles of aquaporin 4 in amyotrophic lateral sclerosis. Neurol Sci. 2019;40:1541&#x2013;1549. doi: 10.1007/s10072-019-03877-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03877-5</ArticleId><ArticleId IdType="pubmed">30980198</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou W, Pu T, Feng W, Lu M, Zheng Y, Du R, Xiao M, Hu G. Blocking meningeal lymphatic drainage aggravates Parkinson&#x2019;s disease-like pathology in mice overexpressing mutated alpha-synuclein. Transl Neurodegener. 2019;8:7. doi: 10.1186/s40035-019-0147-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-019-0147-y</ArticleId><ArticleId IdType="pmc">PMC6396507</ArticleId><ArticleId IdType="pubmed">30867902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosur Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>